These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5610757)

  • 1. [Modifications of urinary hydroxyproline by therapeutic measures with vascular effects (apropos of 25 cases)].
    Recordier AM; Serratrice G; Eisinger J; Valente P; Ragnoni R
    Rhumatologie; 1967; 19(6):223-5. PubMed ID: 5610757
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effects of vasodilative measures on the blood flow into the lower extremities in obliterating vascular diseases].
    HESS H
    Z Klin Med; 1955; 153(1):35-61. PubMed ID: 14386962
    [No Abstract]   [Full Text] [Related]  

  • 3. [Peripheral circulation and osseous metabolism. 1. Effects of vasodilator treatment].
    Eisinger J
    Mars Med; 1968; 105(11):843-4. PubMed ID: 5746235
    [No Abstract]   [Full Text] [Related]  

  • 4. [Management of shock].
    Takatsu T; Kawai C; Tsutsumi J
    Naika; 1968 Jul; 22(1):65-79. PubMed ID: 5708412
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic results of a new vasodilator in severe circulatory disorders of the lower extremities].
    WEGHAUPT K
    Wien Klin Wochenschr; 1957 Jan; 69(2):31-2. PubMed ID: 13409874
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of the administration of fluorine on osseous phosphatase and on urinary hydroxyproline in patients with fluorosis].
    Fradà G; Pintacuda S; Di Blasi S
    Boll Soc Ital Biol Sper; 1974 Nov; 50(22):1959-62. PubMed ID: 4462789
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hydroxyproline excretion in the urine in destructive bone processes].
    Raab W; Schwägerl W
    Wien Klin Wochenschr; 1967 Jan; 79(2):32-5. PubMed ID: 6031951
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary hydroxyproline excretion in generalized bone diseases].
    Czitober H; Raab W
    Wien Z Inn Med; 1967; 48(10):401-8. PubMed ID: 5620579
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic control of the path of the blood flow of the end organs].
    Gersmeyer EF; Leicht E
    Med Welt; 1967 Feb; 8():426-31. PubMed ID: 6044562
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on urinary hydroxyproline.
    Ogane S
    Fukushima J Med Sci; 1969 May; 15(3):97-109. PubMed ID: 5262427
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rarefying osteopathy in rheumatology. Methods of evaluation and comparison of urinary hydroxyproline and serum proline iminopeptidase].
    D'Amore M; Quarto S; Terlizzi N; Martiradonna A; Carrozzo M
    Minerva Med; 1980 Jul; 71(29):2045-51. PubMed ID: 6967571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of vasodilator drugs on the inflow of blood into the lower extremities in obliterative vascular diseases].
    HESS H
    Z Klin Med; 1956; 154(2):165-83. PubMed ID: 13393181
    [No Abstract]   [Full Text] [Related]  

  • 13. [Valve and significance of urinary hydroxyproline in osseous pathology].
    Hioco D; Gruson M; Ryckewaert A; de Sèze S
    Ann Biol Clin (Paris); 1967; 25(5):725-34. PubMed ID: 6059731
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasodilator drugs in occlusive vascular disease of lower limb: a preliminary report.
    GILLESPIE JA
    J R Coll Surg Edinb; 1958 Sep; 4(1):38-9. PubMed ID: 13588648
    [No Abstract]   [Full Text] [Related]  

  • 15. Arlidin in the treatment of peripheral vascular diseases.
    MURPHY HL; KLASSON DH
    N Y State J Med; 1957 Jun; 57(11):1908-10. PubMed ID: 13430945
    [No Abstract]   [Full Text] [Related]  

  • 16. [Internal treatment of peripheral vascular diseases].
    BUGAR-MESZAROS K
    Orv Hetil; 1954 Feb; 95(9):238-40. PubMed ID: 13166272
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined therapy with vasodilator drugs and enzymes in peripheral arterial diseases].
    NARDINI A; FERUGLIO G
    Folia Cardiol; 1957 Dec; 16(6):575-88. PubMed ID: 13512400
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical and laboratory comparison of the effects of commonly used vasodilator drugs on arterial diseases.
    STALLWORTH JM; LEE WH; BELISLE C; NUNN DB
    Am Surg; 1958 Oct; 24(10):700-8. PubMed ID: 13583455
    [No Abstract]   [Full Text] [Related]  

  • 19. Total urinary hydroxyproline in osteomalacia and the effect upon it of treatment with vitamin D.
    Smith R; Dick M
    Clin Sci; 1968 Feb; 34(1):43-56. PubMed ID: 5640685
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct intra-arterial therapy in occlusive vascular disease.
    GUEUKDJIAN SA
    Cyprus Med J; 1954 Dec; 7(7):109-13. PubMed ID: 14365211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.